Navigation auf


Center for Molecular Cardiology

Editorial on hypertrophic cardiomyopathy


Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disorder worldwide. Since its first comprehensive description nearly six decades ago, HCM has emerged as a highly heterogeneous disease with diverse genetic background, clinical presentation and natural history. While many patients with HCM remain free of symptoms and adverse events, a significant proportion of affected individuals evolve along discrete disease pathways – most commonly leading to heart failure. A must-read editorial on this topic, by Wenzl F., Ambrosini S. and Paneni F. - published recently in the International Journal of Cardiology.